Approval · Notice of Compliance 1498 · 2000
ZOMETA: Notice of Compliance 1498
Issued August 21, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1498
- Date
- August 21, 2000
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Bone metabolism regulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZOMETA | 02242725 | Cancelled Post Market |
Medicinal ingredients
- ZOLEDRONIC ACID 4 MG per VIAL